BG
SLXP

BlackRock Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlackRock Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-224,474
Closed -$38.8M – 3011
2015
Q1 		$38.8M Sell
224,474
-77,867
-26% -$11.4M 0.02% 656
2014
Q4 		$34.8M Buy
302,341
+198,557
+191% +$24.1M 0.02% 678
2014
Q3 		$16.2M Sell
103,784
-97,732
-48% -$14.2M 0.01% 846
2014
Q2 		$24.9M Buy
201,516
+157,891
+362% +$17.5M 0.01% 737
2014
Q1 		$4.52M Buy
43,625
+9,762
+29% +$1,000K ﹤0.01% 1148
2013
Q4 		$3.04M Buy
33,863
+1,986
+6% +$158K ﹤0.01% 1267
2013
Q3 		$2.13M Sell
31,877
-28,221
-47% -$1.94M ﹤0.01% 1444
2013
Q2 		$3.98M Buy
+60,098
New +$3.44M ﹤0.01% 1037

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlackRock Group's SLXP Position: Q2 2015 in Review

BlackRock Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 224,474 shares — an estimated $38.8M sold.

BlackRock Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $38.8M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • BlackRock Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • BlackRock Group sold 224,474 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $38.8M.
  • BlackRock Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • BlackRock Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $38.8M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.